| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/24/2010 | US20100159586 Hybrid Suppressor tRNA for Vertebrate Cells |
| 06/24/2010 | US20100159585 Suppressor tRNA Transcription in Vertebrate Cells |
| 06/24/2010 | US20100159564 Protease resistant recombinant bacterial collagenases |
| 06/24/2010 | US20100159545 Method for production of corosolic acid in suspension culture of plant cells |
| 06/24/2010 | US20100159525 Extranuclear RNA Splicing in Neuronal Dendrites |
| 06/24/2010 | US20100159524 Apparatus and methods for producing and using high-density cells and products therefrom |
| 06/24/2010 | US20100159512 Method for the preparation of recombinant human thrombin and fibrinogen |
| 06/24/2010 | US20100159511 Production of recombinant selenoprotein mutants with enhanced catalytic activity |
| 06/24/2010 | US20100159499 Nanoparticulate cell culture surface |
| 06/24/2010 | US20100159477 Reagents for the detection of protein phosphorylation in signaling pathways |
| 06/24/2010 | US20100159468 Small molecule inhibition of intracellular transport |
| 06/24/2010 | US20100159467 Method for replicating the hepatitis c virus |
| 06/24/2010 | US20100159465 Screening of Abundantly Secreted Proteins and Their Use as Fusion Partners for the Production of Recombinant Proteins |
| 06/24/2010 | US20100159462 Tunable elastomeric nanochannels for nanofluidic manipulation |
| 06/24/2010 | US20100159459 Production of reprogrammed cells with restored potential |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100159443 Disease model incorporation into an artificial immune system (ais) |
| 06/24/2010 | US20100159065 Method for speeding up plant growth and improving yield by introducing phosphatases in transgenic plant |
| 06/24/2010 | US20100159022 Bone induction system and methods |
| 06/24/2010 | US20100158977 Progenitor cells from urine and methods for using the same |
| 06/24/2010 | US20100158975 Extracellular matrix compositions |
| 06/24/2010 | US20100158955 Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity |
| 06/24/2010 | US20100158952 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates |
| 06/24/2010 | US20100158947 Permissive cells and uses thereof |
| 06/24/2010 | US20100158936 Immunostimulatory compositions and methods |
| 06/24/2010 | US20100158934 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/24/2010 | US20100158933 Ige ch3 peptide vaccine |
| 06/24/2010 | US20100158932 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 06/24/2010 | US20100158931 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 06/24/2010 | US20100158927 Antibodies, methods and kits for diagnosing and treating melanoma |
| 06/24/2010 | US20100158926 Antibodies to erbb2 |
| 06/24/2010 | US20100158923 Reducing polyglutamine-based aggregation |
| 06/24/2010 | US20100158922 Anti-Interferon Gamma Antibodies and Methods of Use Thereof |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158911 Compositions and Methods of Treating Disease with FGFR Fusion Proteins |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158902 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 06/24/2010 | US20100158900 Anti-marinobufagenin antibodies and methods for their use |
| 06/24/2010 | US20100158891 Human Coagulation Factor VII Variants |
| 06/24/2010 | US20100158881 Activated dual specificity lymphocytes and their methods of use |
| 06/24/2010 | US20100158879 Expression cassette and vector for transient or stable expression of exogenous molecules |
| 06/24/2010 | US20100158878 Target populations of oligodendrocyte precursor cells and methods of making and using same |
| 06/24/2010 | US20100158876 Process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cells obtainable by this process |
| 06/24/2010 | US20100158874 Compositions and Methods for Treating Peripheral Vascular Diseases |
| 06/24/2010 | US20100158873 Method for extracting and selecting cells |
| 06/24/2010 | US20100158872 Cardiomyocyte Cell Populations |
| 06/24/2010 | US20100158868 Use of Fetal Cells for the Treatment of Genetic Diseases |
| 06/24/2010 | US20100158805 Quantum dot labeled stem cells for use in cardiac repair |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | DE102004062386B4 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 06/24/2010 | CA2747794A1 Treatment of lung and pulmonary diseases and disorders |
| 06/24/2010 | CA2747758A1 Regeneration and repair of neural tissue following injury |
| 06/24/2010 | CA2747757A1 Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
| 06/24/2010 | CA2747678A1 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 06/24/2010 | CA2747207A1 Pharmaceutical preparation |
| 06/24/2010 | CA2747120A1 Methods of modulating the sex of avians |
| 06/24/2010 | CA2746775A1 Cell transport system |
| 06/24/2010 | CA2745218A1 Feed supplement for mammalian cell culture and methods of use |
| 06/24/2010 | CA2728215A1 Methods for enhanced propagation of cells |
| 06/23/2010 | EP2199795A2 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 06/23/2010 | EP2199793A1 Method of evaluating human dendritic cells and human cell immunotherapeutic agent |
| 06/23/2010 | EP2199397A2 Plants having modified growth characteristics and a method for making the same |
| 06/23/2010 | EP2199391A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 06/23/2010 | EP2199388A1 Udp-glucuronyl transferase and polynucleotide encoding the same |
| 06/23/2010 | EP2199385A1 Specific and persistent activation of heat shock response in cell lines using a viral factor |
| 06/23/2010 | EP2199384A1 A porous membrane device that promotes the differentiation of monocytes into dendritic cells |
| 06/23/2010 | EP2199383A1 Methods for the preparation of fibroblasts |
| 06/23/2010 | EP2198723A1 Inflammation inhibiting compounds |
| 06/23/2010 | EP2198015A1 Composition for separating spermatozoa from a semen sample |
| 06/23/2010 | EP2198014A1 Non-conventional nkt cells for use in cancer therapy |
| 06/23/2010 | EP2198013A1 An in vitro beating heart model |
| 06/23/2010 | EP2198012A1 Cardiomyocyte-like cell clusters derived from hbs cells |
| 06/23/2010 | EP2198011A1 Wnt pathway stimulation in reprogramming somatic cells |
| 06/23/2010 | EP2198010A2 Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes |
| 06/23/2010 | EP2198009A1 Cell culture article and methods thereof |
| 06/23/2010 | EP2198004A2 Non-invasive automated cell proliferation apparatus |
| 06/23/2010 | EP1960513B1 Non-woven fabric for biomedical application based on poly (ester-amide)s |
| 06/23/2010 | EP1670309B1 Transgenic animals with serious disorders related to alzheimer's disease |
| 06/23/2010 | EP1572748B1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 06/23/2010 | EP0948628B1 Method for the production of glycerol by recombinant organisms |
| 06/23/2010 | CN1981030B Follicular fluid for prolonged growth and survival of cells for cell therapies |
| 06/23/2010 | CN1876819B Genetically engineered duckweed |
| 06/23/2010 | CN1871351B Novel fungal proteins and nucleic acids encoding same |
| 06/23/2010 | CN1871256B Muteins of tear lipocalin |
| 06/23/2010 | CN1824773B Human testicle specificity protein 50 gene expression regulator screening system and method of screening its gene expression regulator |
| 06/23/2010 | CN101755046A Method for the preparation of dermal papilla tissue employing mesenchymal stem cells |
| 06/23/2010 | CN101755045A Method for production of dendritic cell |
| 06/23/2010 | CN101755044A Preservation of bioactive materials by freeze dried foam |
| 06/23/2010 | CN101754767A Treatment of graft-versus-host disease |
| 06/23/2010 | CN101748149A Plasmid containing HCV genome, cell, system and method for screening drug |
| 06/23/2010 | CN101748141A 3-hydroxyl-3-mathylglutaryl-CoA reductase albumen of barbadosnut and encoding gene thereof |
| 06/23/2010 | CN101748134A Method for realizing growth of microorganisms at temperature higher than extreme growth temperature |
| 06/23/2010 | CN101748104A Levan hydrolase, coding gene thereof and use thereof |
| 06/23/2010 | CN101748100A Rat induced multipotent stem cells and preparation method thereof |
| 06/23/2010 | CN101748099A Noble cell of human embryonic stem cell for stably expressing HLA-G molecules |
| 06/23/2010 | CN101748098A Breast cancer transplantable tumor spontaneous metastasis model and application thereof |
| 06/23/2010 | CN101748061A Device for establishing single-cell level connection between neurons and growth connecting method |
| 06/23/2010 | CN101748060A Device and method for arranging a plurality of cells at same plane and controlling cells |
| 06/23/2010 | CN101748059A Micro-fluidic chip and method for research on oriented movement of cell in three-dimensional medium |
| 06/23/2010 | CN101747440A TNFR-Fc fusion protein and usage thereof |